Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$1.3M Buy
23,434
+10,534
+82% +$570K 0.1% 100
2024
Q4
$622K Sell
12,900
-1,813
-12% -$92.2K 0.05% 149
2024
Q3
$848K Buy
14,713
+4,861
+49% +$262K 0.06% 126
2024
Q2
$478K Buy
9,852
+4,685
+91% +$226K 0.04% 169
2024
Q1
$251K Buy
+5,167
New +$252K 0.02% 236

Other funds holding SNY

Callan Capital's SNY Position: Q1 2025 in Review

Callan Capital increased its Sanofi (SNY) stake by 82% in Q1 2025, buying an estimated $570K and bringing the position to 23,434 shares worth $1.3M. The position accounts for 0.1% of the portfolio, ranked #100.

Callan Capital first reported a position in SNY in Q1 2024 and has held it in 5 quarters since. 773 funds tracked by Wall St. Rank hold SNY as of Q1 2025.

  • Callan Capital held 23,434 shares of Sanofi worth $1.3M as of Q1 2025.
  • Callan Capital bought 10,534 Sanofi shares in Q1 2025, an estimated $570K.
  • Sanofi made up 0.1% of Callan Capital's portfolio in Q1 2025, its #100 holding.
  • Callan Capital first reported a position in Sanofi in Q1 2024 and has held it in 5 quarters since.
  • 773 funds tracked by Wall St. Rank held Sanofi as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.